News ‘In Public Interest’: Bharat Biotech Affirms Covaxin Safety Amid AstraZeneca Debate Bharat Biotech said all the studies and safety follow-up activities demonstrated “excellent safety record, without any vaccine-associated incidents of blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc” Post navigation Previous: News18 Evening Digest: Amit Shah on ‘Conspiracy To Kill Kejriwal’ Charge; Ticket To Brij Bhushan and Other Top StoriesNext: Hoax Bomb Threat: Delhi Cops Contact Interpol For Info On Sender’s IP Address From Russian Agencies More Stories News Indian National Held By US Immigration In San Diego Over His ‘Criminal History’ Of Hit-And-Run News Happy Women’s Day 2026: Women Leaders In Politics Globally News 90-Year-Old Woman Gang-Raped By Four Men In Madhya Pradesh; SIT Launches Probe